Stevanato Group SpA (STVN)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $4.32B
Last updated: Nov 17, 2026 at 4:10 PM ET
Stevanato Group SpA (STVN) Statistics
Stevanato Group SpA (STVN) has a market cap of $4.32B. Its trailing P/E is 19.5x.
Total Valuation
| Market Cap | $4.32B |
|---|---|
| Latest price (Nov 17, 2026) | $15.27 |
Key Dates
The next earnings report is expected on Mar 2, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Jun 11, 2026.
| Next Earnings Date | Mar 2, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 3, 2026 |
| Last Ex-Dividend Date | Jun 11, 2026 |
| Last Payment Date | Jul 29, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.9x and 2.3x.
| P/E Ratio | 19.5x |
|---|---|
| P/S Ratio | 2.9x |
| P/B Ratio | 2.3x |
| P/TBV Ratio | 2.5x |
| PEG Ratio | 1.1 |
Price Statistics
The stock is down 30.59% over 52 weeks and trades 19.42% below its 50-day average.
| Beta (1Y) | 0.83 |
|---|---|
| 52-Week Change | -30.59% |
| 1-Month Change | -19.72% |
| 3-Month Change | -29.66% |
| 6-Month Change | -11.57% |
| 5-Year Change | -24.50% |
| Total Return (1Y) | -30.31% |
| Total Return (3Y CAGR) | -17.24% |
| Total Return (5Y CAGR) | -7.24% |
| Return vs SPY (1Y) | -38.02% |
| Max Drawdown (1Y) | -43.42% |
| Max Drawdown (3Y) | -61.10% |
| Sharpe Ratio (1Y) | -0.54 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $18.95 |
| 200-Day Average | $17.89 |
| 52-Week Range | $12.05 to $23.92 |
| RSI (14 Days) | 39.9 |
| Average Volume (20 Days) | 1.30M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.73x current liabilities, and total debt is 0.29x shareholder equity.
| Current Ratio | 1.73x |
|---|---|
| Quick Ratio | 1.19x |
| Debt / Equity | 0.29x |
| Debt / EBITDA | 1.47x |
| Interest Coverage | 20.05x |
Returns and Efficiency
Return on invested capital is 7.13% over the last 12 months, against a 5-year average of 9.35%.
| Return on Equity (ROE) | 8.92% |
|---|---|
| Return on Assets (ROA) | 5.33% |
| Return on Invested Capital (ROIC) | 7.13% |
| Return on Capital Employed (ROCE) | 9.81% |
| ROE (5Y Average) | 12.11% |
| ROA (5Y Average) | 7.09% |
| ROIC (5Y Average) | 9.35% |
| Asset Turnover | 0.49x |
| Inventory Turnover | 2.92x |
| Receivables Turnover | 2.33x |
| Cash Conversion Cycle | 179 days |
Taxes
Income tax took 30.70% of pretax income over the last 12 months.
| Income Tax (TTM) | EUR 61.94M |
|---|---|
| Effective Tax Rate | 30.70% |
Scores
STVN has an Altman Z-Score of 3.54, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.54 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of EUR 1.24B over the last 12 months is up 6.20% from the 12 months before.
| Revenue | EUR 1.24B |
|---|---|
| Revenue Growth (YoY) | +6.20% |
| Gross Profit | EUR 362.31M |
| Operating Income | EUR 200.77M |
| Pretax Income | EUR 201.77M |
| Net Income | EUR 139.73M |
| EBITDA | EUR 306.09M |
| EBIT | EUR 207.21M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 59.55% of the EUR 2.67B in total assets.
| Working Capital | EUR 404.46M |
|---|---|
| Shareholder Equity | EUR 1.59B |
| Tangible Book Value | EUR 1.50B |
| Total Assets | EUR 2.67B |
| Total Liabilities | EUR 1.07B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After EUR 256.05M of capital spending, operating cash flow left EUR -78.07K of free cash flow.
| Operating Cash Flow | EUR 255.97M |
|---|---|
| Capital Expenditures | EUR 256.05M |
| Free Cash Flow | EUR -78.07K |
| Depreciation and Amortization | EUR 98.87M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 16.15%, against a 5-year average of 17.59%.
| Gross Margin | 29.15% |
|---|---|
| Operating Margin | 16.15% |
| Pretax Margin | 16.23% |
| Net Margin | 11.24% |
| EBITDA Margin | 24.63% |
| EBIT Margin | 16.67% |
| FCF Margin | -0.01% |
| Gross Margin (5Y Average) | 30.33% |
| Operating Margin (5Y Average) | 17.59% |
| Net Margin (5Y Average) | 13.26% |
Growth
Revenue grew 5.02% a year over 3 years.
| Revenue Growth (3Y CAGR) | +5.02% |
|---|---|
| Revenue Growth (5Y CAGR) | +11.47% |
| FCF Growth (5Y CAGR) | -18.51% |
| Operating Income Growth (3Y CAGR) | -1.65% |
Dividends and Yields
STVN pays out 10.51% of earnings as dividends.
| Dividend Per Share (Annual) | $0.06 |
|---|---|
| Dividend Yield | 0.41% |
| Payment Schedule | Annual |
| Dividend Growth (3Y CAGR) | +4.71% |
| Payout Ratio | 10.51% |
| Earnings Yield | 5.13% |
| FCF Yield | 0.00% |
Peer Position
Against 11 similar companies, STVN has the 10th highest P/E and the 8th highest P/S.
P/E RatioPeer median 26.1x
P/S RatioPeer median 3.4x
ROICPeer median 6.96%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.42%
Dividend YieldPeer median 0.00%
| P/E Ratio | 19.5x vs 26.1x median |
|---|---|
| P/S Ratio | 2.9x vs 3.4x median |
| ROIC | 7.13% vs 6.96% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +6.20% vs +9.42% median |
| Dividend Yield | 0.41% vs 0.00% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About STVN
What is STVN's market cap?
Stevanato Group SpA has a market cap of $4.32B.
What is STVN's P/E ratio?
Stevanato Group SpA has a trailing P/E ratio of 19.5x.
How many shares of STVN are outstanding?
Stevanato Group SpA has 273.10M shares outstanding. The count is up 0.04% from a year earlier.
Does STVN pay a dividend?
Yes. Stevanato Group SpA pays $0.06 a share a year, a dividend yield of 0.41%.
STVN pages: Overview, Charting, Financials, Statistics, Valuation, Competitors